Professor Michael Sherburn, from the Research School of Chemistry
via ANU
Chemists have developed a revolutionary new way to manufacture natural chemicals by clipping smaller molecules together like Lego. They have used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin.
“We took small molecules and clipped them together like Lego,” said lead researcher Professor Michael Sherburn, from the Research School of Chemistry.
“The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It’s quite magical. This means you can efficiently build large and complex molecules.”
Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.
“This leads to a lot of waste,” Professor Sherburn said.
The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.
The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.
Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.
“Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances,” said Dr Chris Newton, who did the research in the laboratory as a PhD student.
The Latest on: Manufacturing new drugs
via Google News
The Latest on: Manufacturing new drugs
- AnaptysBio takes a beating as its lead drug fails its first PhII test. And 5 more trials are nearing a readouton March 8, 2021 at 7:04 am
AnaptysBio shares got hammered Monday morning after the biotech conceded defeat for the first mid-stage test of its lead drug. Its antibody imsidolimab performed around as well as a placebo in ...
- Contract Development Manufacturing Organizations Global Market Report 2021: COVID-19 Growth And Changeon March 8, 2021 at 5:22 am
Major players in the contract development manufacturing organizations market are Recipharm AB. , Patheon Inc. , Boehringer Ingelheim International, Catalent Inc. , Lonza Group Ltd. , Thermo Fisher ...
- U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorderson March 8, 2021 at 4:04 am
FDA designation will facilitate development and expedited review of company’s lead gene therapy product candidates for life-threatening diseases with unmet medical needs: PBGM01 for GM1 gangliosidosis ...
- Bacteria Reprogrammed to Make Designer Molecule Used in Pharmaceutical Drugson March 8, 2021 at 3:17 am
Process paves a road to safe, ethical, and fast drug manufacturing. Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer ...
- What you need to know about the new Johnson & Johnson vaccineon March 8, 2021 at 3:04 am
This vaccine requires only one dose and uses slightly different technology to fight the virus. Like you, WHYY’s Health Desk Help Desk wanted to know more.
- Hospital Injectable Drugs Market 2021 Top manufacturers Records, Size, Market Share & Trends Analysis 2021-2026on March 8, 2021 at 1:54 am
In 2021, “ Hospital Injectable Drugs Market “ Size, Status and Market Insights, Forecast to 2027 Drug injection is a ...
- New antiviral COVID-19 drug quickly reduces virus, drugmaker Merck reportson March 6, 2021 at 6:09 am
New Jersey-based Merck said Saturday that the experimental antiviral drug molnupiravir it has been developing with Ridgeback Bio showed a quick reduction of the infectious virus in a study among ...
- N.J. drugmaker Merck reports new antiviral COVID drug quickly reduces viruson March 6, 2021 at 4:01 am
New Jersey-based Merck said Saturday that the experimental antiviral drug molnupiravir it has been developing with Ridgeback Bio showed a quick reduction of the infectious virus in a study among ...
- How Drug Cos. Can Adapt To New Reference Pricing Ruleson March 5, 2021 at 3:43 pm
Considering the Trump administration's aggressive drug reference pricing rules, and more price control measures potentially on the horizon, drug and biotech companies should prepare a comprehensive ...
- Elkton man arrested for manufacturing drugson March 4, 2021 at 11:49 am
The Huron County Drug Task Force, with the support of several agencies, executed a search warrant and arrested a 31-year-old Elkton man for manufacturing drugs March 3. According to Huron County ...
via Bing News
